Using PET/MRI scans to study knee artery embolization for knee osteoarthritis
Studies scan changes after genicular artery embolization in people with knee osteoarthritis pain.
Key facts
- Who runs it
- Lucas R. Cusumano, MD
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Registry title
- IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success
- Status
- Recruiting
- People taking part
- 25 people, planned
- Starts
- 30 Dec 2026
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional
- Treatments tested
- Embolization
- Record updated
- 12 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with knee osteoarthritis and moderate to severe knee pain who will have genicular artery embolization (GAE), a procedure that blocks small blood vessels in the knee. PET/MRI scans will be used to study changes in the knee.
- Age
- 40 years or older
- Sex
- All sexes
- Disease stage
- Knee osteoarthritis seen on X-ray, Kellgren-Lawrence score > 2 on an X-ray taken within 3 months of the procedure. Moderate to severe knee pain, pain score > 5 out of 10. People who cannot have knee surgery or who refuse it.
- Earlier treatment
- Conservative treatment did not help or stopped working for at least 3 months (for example NSAIDS, physical therapy, steroid joint injection or hyaluronic acid joint injection). People with a prior total or partial knee replacement in the knee being studied cannot join.
Main reasons for not taking part
- Reduced kidney function, estimated glomerular filtration rate of less than 45 mL/min
- Allergy to iodinated contrast dye, or bleeding problems that cannot be corrected
- Fibromyalgia, autoimmune or inflammatory disease, or back surgery, spine injections or leg pain coming from the spine
- Active infection or cancer, active pregnancy, or cigarette use now or within 12 months
- Pacemaker, aneurysm clips, neurostimulators or other metal implants not safe for PET/MRI; knee bent more than 20 degree inward or outward; severe artery hardening
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Provided informed consent
- Age ≥ 40 years
- Ineligibility for or refusal of surgical management
- Moderate-severe knee pain as determined by visual analog scale > 5 out of 10
- Osteoarthritis based on X-ray. Kellgren-Lawrence score > 2 based on radiograph completed within 3 months of procedure date
- Resistant/failed some form of conservative treatment (e.g. NSAIDS/physical therapy/steroid joint injection/hyaluronic acid joint injection) for at least 3 months
- Able to comply with all treatments and protocol follow-up visits
Who cannot take part
- Prior total or partial knee replacement in the subject knee
- Presence of pacemakers, aneurysm clips, neurostimulators, or any other metal implant not compatible with PET/MRI
- History of fibromyalgia, autoimmune, or inflammatory disorder
- History of any lumbar spine surgery, spine injections, or radicular pain in the extremity believed to originate from the spine
- Allergy to iodinated contrast agents
- Active infection or malignancy
- Uncorrectable bleeding diathesis
- Mild knee pain as determined by visual analog scale < 5 out of 10
- OA on knee radiograph resulting in greater than 20 degree varus or valgus angulation
- Moderate loss of kidney function, define as estimated glomerular filtration rate of less than 45 mL/min
- Significant arterial atherosclerosis that would limit selective angiography
- Recent (within 12 months) or active cigarette use
- Active pregnancy
Where in United States
- University of California, Los AngelesLos Angeles, United StatesContact: Rayne ShepardTaking people
About the trial
What the trial wants to find out
Several clinical trials on genicular artery embolization (GAE) show significant clinical benefit for the majority of patients. However, a proportion of patients do not benefit from GAE, and responses vary across individual patients. Changes in metabolic activity on non-invasive imaging may correlate with improvement in symptoms of knee osteoarthritis. This study will assess changes in metabolic uptake on a hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) system in subjects undergoing GAE.
The group in the trial
- TreatmentOther group
Treatment with GAE
Treatment: Embolization
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success
- Plain-language title
- Using PET/MRI scans to study knee artery embolization for knee osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 12 November 2026